ORPHIC THERAPEUTICS

Serial Number 86353974
606

Registration Progress

Application Filed
Jul 31, 2014
Under Examination
Apr 7, 2015
Approved for Publication
Feb 10, 2015
Published for Opposition
Feb 10, 2015
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: ORPHIC THERAPEUTICS
Previous Owner: ORPHIC THERAPEUTICS, INC.
Classes: 005

Trademark Image

ORPHIC THERAPEUTICS

Basic Information

Serial Number
86353974
Filing Date
July 31, 2014
Published for Opposition
February 10, 2015
Abandonment Date
November 13, 2017
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Nov 13, 2017
Classes
005

Rights Holder

ORPHIC THERAPEUTICS, INC.

03
Address
17295 CHESTERFIELD AIRPORT RD. #200
CHESTERFIELD, MO 63005

Ownership History

Orphic Therapeutics, LLC

Original Applicant
16
Fort Mill, SC

Orphic Therapeutics, LLC

Owner at Publication
16
Fort Mill, SC

TVMH THERAPEUTICS, LLC

New Owner After Publication #1
16
FORT MILL, SC

ORPHIC THERAPEUTICS, INC.

New Owner After Publication #2
03
CHESTERFIELD, MO

Legal Representation

Attorney
David B. Jennings

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

41 events
Date Code Type Description Documents
Nov 13, 2017 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Nov 13, 2017 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Apr 7, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 4, 2017 EX4G S SOU EXTENSION 4 GRANTED Loading...
Apr 4, 2017 EXT4 S SOU EXTENSION 4 FILED Loading...
Apr 4, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 23, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 22, 2016 EX3G S SOU EXTENSION 3 GRANTED Loading...
Sep 19, 2016 EXT3 S SOU EXTENSION 3 FILED Loading...
Sep 19, 2016 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 23, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 22, 2016 EX2G S SOU EXTENSION 2 GRANTED Loading...
Mar 21, 2016 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 22, 2016 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Mar 21, 2016 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 25, 2015 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Oct 14, 2015 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Oct 9, 2015 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 7, 2015 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 7, 2015 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 7, 2015 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 7, 2015 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 10, 2015 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 10, 2015 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 21, 2015 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 6, 2015 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Jan 2, 2015 ALIE A ASSIGNED TO LIE Loading...
Dec 15, 2014 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 12, 2014 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Dec 12, 2014 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Dec 12, 2014 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Dec 12, 2014 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Nov 25, 2014 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 24, 2014 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 24, 2014 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 17, 2014 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 17, 2014 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 17, 2014 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 14, 2014 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 8, 2014 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 4, 2014 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical and medicated preparations for human use for the prevention and treatment of genetic and hereditary disorders and tropical diseases affecting the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"THERAPEUTICS"